Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Capricor Therapeutics

Capricor Therapeutics reported $46.6M in Current Assets for its fiscal quarter ending in March of 2023.

Current Assets Change
Bluebird Bio BLUE:US USD 351.07M 151.58M
Capricor Therapeutics CAPR:US USD 46.6M 3.71M
Cytokinetics CYTK:US USD 680.63M 114.56M
Geron GERN:US USD 387.02M 206.78M
Immunic Inc. VTL:US USD 106.58M 19.28M
J&J JNJ:US USD 64.39B 9.09B
Lumos Pharma Inc. NLNK:US USD 63.25M 8.76M
Plus Therapeutics, Inc. CYTX:US USD 13.63M 8.19M
Prothena PRTA:US USD 700.34M 18.76M
PTC Therapeutics PTCT:US USD 613.39M 80.39M
Sarepta Therapeutics SRPT:US USD 2.49B 69.48M
Vascular Biogenics VBLT:US USD 26.97M 4.82M